Pfizer filed a second lawsuit yesterday accusing Danish drugmaker Novo Nordisk of structuring its US$9 billion (RM37.8 ...
Stocktwits on MSN
Novo Nordisk Q3 Preview: Analysts See Profit Drop As Obesity Market Cools, Pfizer Tensions Rise
Analysts expect Novo Nordisk’s Q3 revenue to fall 2% to $11.87 billion and earnings per share to drop as competition from Eli Lilly intensifies. ・The report marks CEO Mike Doustdar’s first since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback